Synergy Asset Management LLC Makes New $350,000 Investment in The Clorox Company (NYSE:CLX)

Synergy Asset Management LLC bought a new stake in shares of The Clorox Company (NYSE:CLX - Free Report) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 2,379 shares of the company's stock, valued at approximately $350,000.

A number of other large investors have also recently modified their holdings of the stock. Redwood Park Advisors LLC purchased a new stake in Clorox in the fourth quarter worth about $26,000. Millstone Evans Group LLC purchased a new stake in Clorox in the fourth quarter worth about $31,000. Wood Tarver Financial Group LLC purchased a new stake in Clorox in the fourth quarter worth about $31,000. GKV Capital Management Co. Inc. purchased a new stake in Clorox in the fourth quarter worth about $32,000. Finally, Aster Capital Management DIFC Ltd purchased a new stake in Clorox in the fourth quarter worth about $33,000. Institutional investors own 78.53% of the company's stock.

Analysts Set New Price Targets

CLX has been the topic of a number of recent analyst reports. Morgan Stanley cut their price target on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Evercore ISI set a $140.00 price target on shares of Clorox and gave the company an "underperform" rating in a report on Tuesday, May 6th. Citigroup cut their price target on shares of Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a report on Monday, April 14th. Barclays cut their price target on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a report on Wednesday, May 7th. Finally, UBS Group lowered their price objective on shares of Clorox from $176.00 to $154.00 and set a "neutral" rating on the stock in a research report on Thursday, April 17th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat.com, Clorox currently has a consensus rating of "Hold" and a consensus price target of $151.23.

Clorox Stock Performance

NYSE:CLX traded up $1.56 during trading hours on Monday, hitting $122.33. 1,687,291 shares of the company were exchanged, compared to its average volume of 1,364,125. The stock has a market capitalization of $15.08 billion, a price-to-earnings ratio of 21.96, a PEG ratio of 2.73 and a beta of 0.54. The Clorox Company has a 52-week low of $120.33 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 13.07, a current ratio of 0.74 and a quick ratio of 0.44. The company's 50 day moving average price is $132.74 and its 200-day moving average price is $146.30.

Clorox (NYSE:CLX - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). The company had revenue of $1.67 billion for the quarter, compared to analysts' expectations of $1.74 billion. Clorox had a return on equity of 324.23% and a net margin of 9.89%. The firm's revenue for the quarter was down 8.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.71 EPS. As a group, research analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Insider Activity

In other news, Director Pierre R. Breber bought 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was purchased at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the purchase, the director now directly owns 4,000 shares in the company, valued at approximately $546,280. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.57% of the company's stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.